Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
32
ASUR Quote, Financials, Valuation and Earnings
Last price:
$10.12
Seasonality move
:
5.09%
Day range:
$9.58 - $10.40
52-week range:
$6.89 - $12.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.19x
P/B ratio:
1.38x
Volume:
184.8K
Avg. volume:
97K
1-year change:
20.17%
Market cap:
$271.7M
Revenue:
$119.8M
EPS (TTM):
-$0.45
Analysts' Opinion
-
Consensus RatingAsure Software has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.33, Asure Software has an estimated upside of 42.34% from its current price of $10.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $10.07.
Fair Value
-
According to the consensus of 6 analysts, Asure Software has 42.34% upside to fair value with a price target of $14.33 per share.
ASUR vs. S&P 500
-
Over the past 5 trading days, Asure Software has overperformed the S&P 500 by 5.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Asure Software does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Asure Software has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Asure Software reported revenues of $30.8M.
Earnings Growth
-
Asure Software has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Asure Software reported earnings per share of -$0.12.
Enterprise value:
263M
EV / Invested capital:
1.25x
Price / LTM sales:
2.19x
EV / EBIT:
819.94x
EV / Revenue:
2.20x
PEG ratio (5yr expected):
-2.29x
EV / Free cash flow:
-17.83x
Price / Operating cash flow:
19.48x
Enterprise value / EBITDA:
19.18x
Gross Profit (TTM):
$82.1M
Return On Assets:
-2.68%
Net Income Margin (TTM):
-9.83%
Return On Equity:
-6%
Return On Invested Capital:
-5.79%
Operating Margin:
-8.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $95.8M | $119.1M | $119.8M | $26.3M | $30.8M | |
| Gross Profit | $62.5M | $85.5M | $82.1M | $17.8M | $20.9M | |
| Operating Income | -$11.3M | -$3M | -$10.7M | -$3.8M | -$2.5M | |
| EBITDA | $10.5M | $17.1M | $13.7M | $1.8M | $4M | |
| Diluted EPS | -$0.71 | -$0.41 | -$0.45 | -$0.15 | -$0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $356.8M | $249.8M | $243.3M | $267.2M | $237.3M | |
| Total Assets | $514M | $433.2M | $419.9M | $443.9M | $436.6M | |
| Current Liabilities | $348.6M | $232.8M | $235.2M | $241.3M | $223.6M | |
| Total Liabilities | $368.3M | $275M | $274.8M | $252.2M | $239.3M | |
| Total Equity | $145.7M | $158.2M | $145.1M | $191.7M | $197.3M | |
| Total Debt | $24.5M | $35M | $34.9M | $4.3M | $12.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $13.7M | $18.9M | $9.4M | $7.1M | $9.8M | |
| Cash From Investing | -$36M | -$29.5M | -$19.3M | -$11.3M | -$1M | |
| Cash From Financing | -$12.4M | $24.2M | -$22M | $45.6M | $4.2M | |
| Free Cash Flow | $4.8M | $2.6M | -$14.7M | -$2.1M | $6.3M | |
ASUR
Sector
Market Cap
$271.7M
$618.1M
Price % of 52-Week High
79.04%
74.1%
Dividend Yield
0%
0%
Shareholder Yield
-1.33%
2.42%
1-Year Price Total Return
20.17%
-6.88%
Beta (5-Year)
0.604
0.889
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$9.78
200-day SMA
Buy
Level
$9.47
Bollinger Bands (100)
Sell
Level
9.07 - 11.41
Chaikin Money Flow
Sell
Level
-15.3M
20-day SMA
Sell
Level
$10.26
Relative Strength Index (RSI14)
Sell
Level
46.20
ADX Line
Sell
Level
18.9
Williams %R
Neutral
Level
-51.1416
50-day SMA
Sell
Level
$11.16
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
42.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.1182)
Sell
CA Score
(Annual)
Level (-0.7268)
Buy
Beneish M-Score
(Annual)
Level (-2.3526)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.1727)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its HCM products majorly in the United States.
Stock Forecast FAQ
In the current month, ASUR has received 6 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ASUR average analyst price target in the past 3 months is $14.33.
-
Where Will Asure Software Stock Be In 1 Year?
According to analysts, the consensus estimate is that Asure Software share price will rise to $14.33 per share over the next 12 months.
-
What Do Analysts Say About Asure Software?
Analysts are divided on their view about Asure Software share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Asure Software is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Asure Software's Price Target?
The price target for Asure Software over the next 1-year time period is forecast to be $14.33 according to 6 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ASUR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Asure Software is a Buy. 6 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ASUR?
You can purchase shares of Asure Software via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Asure Software shares.
-
What Is The Asure Software Share Price Today?
Asure Software was last trading at $10.12 per share. This represents the most recent stock quote for Asure Software. Yesterday, Asure Software closed at $10.07 per share.
-
How To Buy Asure Software Stock Online?
In order to purchase Asure Software stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
